About this trial
currently, PROMs and PREMs are not routinely collected and compared among medical inpatients of Swiss university hospitals, nor is a standard set of PROMs and PREMs available for use in Swiss hospitals. The project aims to examine trends in patient-reported outcomes (PROMs), including symptoms, quality of life, and distress, in multimorbid hospitalized patients from admission to 30 days post-discharge. It will also investigate whether PROMs at discharge are linked to the risk of readmission or emergency visits and explore how these outcomes differ in patients who receive low-value care. Additionally, the project will assess the relationship between patient-reported experiences (PREMs) and the provision of low-value care during the hospital stay.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
eligible for the LUCID registry (CER-VD AO_2023-00029) [Age ≥ 18 years, hospitalized in one of the five participating university hospitals (Geneva, Lausanne, Bern, Zürich, Basel), after 01.01.2014, and admitted to general internal medicine wards
Multimorbid patients (2 or more chronic diseases, defined as chronic conditions defined by international classification of diseases, 10th revision, codes with an estimated expected duration of at least 6 months or based on a clinical decision.
Acute illness
Signature of study specific informed consent
Disqualifiers
Not able to speak French, German or English
Foreseen length of stay of less than 4 days (estimated by study collaborators)
Prior inclusion in the TRADUCE study
Incapacity of discernment, i.e. cognitive impairment which could interfere with the ability to fill in PROMs tools
Trial population
Patients with 2 or more chronic diseases, hospitalized in general internal medicine divisions of all five Swiss university hospitals
Trial design
Cohort
Prospective
Treatments tested in this trial
Hospitalization
Other interventionThe investigators collect PROMs amongst up to 1000 patients in general internal medicine divisions of all five Swiss university hospitals
Treatment groups
Trial outcomes
Primary outcomes
Correlation of PROMS with the risk of readmission
The primary objective of the project is to explore trends in PROMs (using the Edmonton Symptom Assessment System (ESAS-r), the EQ-5D-5L index,45 and the National Comprehensive Cancer Network (NCCN) distress thermometer) of multimorbid medical hospitalized patients, from admission until 30-days post-discharge. The patients-reported outcomes will consist of patients-reported symptoms, quality of life and distress
Secondary outcomes
Correlation of PROMs at discharge and risk of hospital readmission or ED visits
assess whether PROMs ((using the Edmonton Symptom Assessment System (ESAS-r), the EQ-5D-5L index,45 and the National Comprehensive Cancer Network (NCCN) distress thermometer) at discharge are associated with the risk of hospital readmission or of emergency department visit within the next 30 days;
Exploration of PROMs in patients who receive low-value care
explore whether PROMs ((using the Edmonton Symptom Assessment System (ESAS-r), the EQ-5D-5L index,45 and the National Comprehensive Cancer Network (NCCN) distress thermometer) trends vary in patients who do or do not receive low value care (LVC);
Explore PREMs
Explore information on Patient Reported Experiences Measures (PREMs) using a qualitative questionnaire during patients' stay at the hospital, and whether there is a correlation between the provision of LVC and qualitative analysis of PREMs
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Lausanne Hospitals
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Collaborator
University Hospital, Geneva
Collaborator
University Hospital, Zürich
Collaborator
University Hospital, Basel, Switzerland
Collaborator